Abstract
AbstractIn this narrative review, we will appraise if modification of the length of bypassed small intestine based on measured total small intestinal length could optimize the outcomes of the laparoscopic Roux-en-Y gastric bypass (LRYGB). We provide a summary of carefully selected studies to serve as examples and to draw tentative conclusions of the effects of LRYGB on remission of comorbidities. As the heterogeneity of the included studies varied in terms of outcomes, type of study, length of the bypassed small intestine, and the follow-up, a common endpoint could not be defined for this narrative article. To achieve efficient metabolic outcomes, it is important to carefully choose the small intestine length excluded from the food passage suited best to each individual patient.
Graphical abstract
Funder
University of Eastern Finland (UEF) including Kuopio University Hospital
Publisher
Springer Science and Business Media LLC
Subject
Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Surgery
Reference48 articles.
1. Ramos A, Kow L, Brown W, et al. The International Federation for the Surgery of Obesity and Metabolic Disorders. In: Fifth IFSO Global Registry Report; 2019.
2. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115(12):956–61.
3. Current care guidelines: obesity, adults. Käypä hoito-suositus: Lihavuus, aikuiset. 2020. Duodecim.https://www.kaypahoito.fi/hoi50124
4. Dixon JB, Zimmet P, Alberti KG, et al. International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med. 2011;28(6):628–42.
5. National Institute for Health and Clinical Excellence. Obesity: identification, assessment and management of overweight and obesity in children, young people and adults. 2014:CG189. Available online at: http://www.nice.org.uk/guidance/cg189